Source:http://linkedlifedata.com/resource/pubmed/id/19282652
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-3-13
|
pubmed:abstractText |
Innate immunity plays important roles in host defense against pathogens, but may also contribute to the development of autoimmune diseases under certain conditions. Toll-like receptors (TLRs) recognize various pathogens and induce innate immunity. We herein present a mouse model for chronic pancreatitis, which was induced by TLR3 signaling that generated the Fas/Fas ligand (FasL)-mediated cytotoxicity. An analogue of viral double-stranded RNA, polyinosinic:polycytidylic acid (poly I:C), which is recognized by TLR3, was injected into autoimmune-prone strains: MRL/Mp mice (MRL/+), MRL/Mp mice with a deficit of Fas (MRL/lpr) and MRL/Mp mice with a deficit of functional FasL (MRL/gld). The pancreatitis in MRL/+ mice was initiated by the destruction of pancreatic ductules, and its severity was significantly higher than that in MRL/lpr mice or MRL/gld mice. Using a pancreatic duct epithelial cell line MRL/S-1 newly established from the MRL/gld mouse that lacks FasL, we showed that treatment with poly I:C significantly induced the expression of Fas on the cultured cells. MRL/S-1 cells were destructed when co-cultured with splenocytes bearing intact FasL prepared from MRL/+ or MRL/lpr mice, but the magnitude of cytotoxicity was smaller with splenocytes of MRL/gld mice. Likewise, synthetic FasL protein showed cytotoxicity on MRL/S-1 cells. Furthermore, MRL/S-1 cells expressed higher levels of chemokines after the treatment with poly I:C, suggesting that the poly I:C-mediated induction of chemokines may be responsible for recruitment of lymphoid cells to the pancreatic periductular regions. These findings indicate that TLR3 signaling generates the Fas/FasL-mediated cytotoxicity, thereby leading to the development of chronic pancreatitis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines,
http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Poly I-C,
http://linkedlifedata.com/resource/pubmed/chemical/TLR3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptor 3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1349-3329
|
pubmed:author |
pubmed-author:AritaNorimasaN,
pubmed-author:FujinoTakahiroT,
pubmed-author:HiasaYoichiY,
pubmed-author:KamadaKazuoK,
pubmed-author:KomoriHiroakiH,
pubmed-author:MatsuuraBunzoB,
pubmed-author:MiyazakiTatsuhikoT,
pubmed-author:NAUMANR DRD,
pubmed-author:OnjiMorikazuM,
pubmed-author:SogaYoshikoY,
pubmed-author:TanakaYukiY,
pubmed-author:TeradaMihoM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
217
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-84
|
pubmed:meshHeading |
pubmed-meshheading:19282652-Animals,
pubmed-meshheading:19282652-Cell Line,
pubmed-meshheading:19282652-Chemokines,
pubmed-meshheading:19282652-Cytotoxicity, Immunologic,
pubmed-meshheading:19282652-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:19282652-Epithelial Cells,
pubmed-meshheading:19282652-Fas Ligand Protein,
pubmed-meshheading:19282652-Gene Expression Regulation,
pubmed-meshheading:19282652-Immunity, Innate,
pubmed-meshheading:19282652-Immunohistochemistry,
pubmed-meshheading:19282652-Mice,
pubmed-meshheading:19282652-Mice, Mutant Strains,
pubmed-meshheading:19282652-Microarray Analysis,
pubmed-meshheading:19282652-Pancreatitis, Chronic,
pubmed-meshheading:19282652-Poly I-C,
pubmed-meshheading:19282652-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19282652-Signal Transduction,
pubmed-meshheading:19282652-Toll-Like Receptor 3
|
pubmed:year |
2009
|
pubmed:articleTitle |
Toll-like receptor 3 signaling induces chronic pancreatitis through the Fas/Fas ligand-mediated cytotoxicity.
|
pubmed:affiliation |
Department of Pathogenomics, Ehime University Graduate School of Medicine, Ehime, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|